Investigating the Impact of B Cell‐Related Genes on Colorectal Cancer Immunosuppressive Environment and Immunotherapy Evasion
Drug Development Research · 2025
DOI: 10.1002/ddr.70053 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Development Research, 2025. Verfasst von Haixia Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, B-Lymphocytes. Die Arbeit nennt 49 Literaturangaben. Gefördert von: This work was supported by the Joint Funds for the National Clinical Key Specialty Construction Program (Grant No. 2021), the Fujian Provincial Clinical Resear….
Abstract (Originalsprache)
We aimed to elucidate the prognostic and immunological roles of B cell‐related genes in colorectal cancer (CRC). This study comprehensively integrated data from single‐cell RNA‐sequencing, TCGA, GEO, IMvigor210, GDSC, CancerSEA, HPA, and TISIDB databases to explore prognostic implications and immunological significance of B cell‐related gene signature in CRC. We identified seven prognostically significant B cell‐related genes for constructing a risk score. Clinical relevance analysis indicated that this risk score served as an independent prognostic factor, with the model accurately predicting patient outcomes. GSEA results implicated the risk score in immune function, cell cycle, and DNA replication. Immune infiltration analysis revealing lower levels of B cells, CD4+ cells, and CD8+ cells in the high‐risk group, correlating with decreased immune activity and function. IMvigor210 and TIDE analysis indicated poorer prognosis among high‐risk group patients receiving immune therapy. Additionally, the high‐risk group exhibited lower sensitivity to immune therapy. Further analysis of drug sensitivity suggested higher resistance to common chemotherapy drugs among high‐risk groups. Finally, we identified HSPA1A as the gene with the strongest association with immune and inflammatory responses. Validation of HSPA1A protein expression and prognosis demonstrated elevated expression in CRC compared to normal colorectal tissue, further reinforcing its association with poorer prognosis and higher tumor stage. The risk score exhibited substantial variations in clinical characteristics, functional mechanism, TMB, drug sensitivity, immune cell infiltration, and immune subtype. Our findings may aid in clinical decision‐making by shedding light on novel and promising biomarkers for CRC prognosis and immunotherapy response prediction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China.
ORCID-Profile: Haixia Wu, Lingdong Shao
Förderung
- This work was supported by the Joint Funds for the National Clinical Key Specialty Construction Program (Grant No. 2021), the Fujian Provincial Clinical Resear…
Zitieren
APA
Wu, H., Yu, Y., Wang, Z., Wu, S., Shao, L., Hong, L., Qiu, J., Zhang, X., & Wu, J. (2025). Investigating the Impact of B Cell‐Related Genes on Colorectal Cancer Immunosuppressive Environment and Immunotherapy Evasion. Drug Development Research. https://doi.org/10.1002/ddr.70053
Vancouver
Wu H, Yu Y, Wang Z, Wu S, Shao L, Hong L, et al. Investigating the Impact of B Cell‐Related Genes on Colorectal Cancer Immunosuppressive Environment and Immunotherapy Evasion. Drug Development Research. 2025. doi:10.1002/ddr.70053
BibTeX
@article{Wu2025,
author = {Wu, Haixia and Yu, Yilin and Wang, Zhiping and Wu, Shiji and Shao, Lingdong and Hong, Liang and Qiu, Jianjian and Zhang, Xueqing and Wu, Junxin},
title = {Investigating the Impact of B Cell‐Related Genes on Colorectal Cancer Immunosuppressive Environment and Immunotherapy Evasion},
journal = {Drug Development Research},
year = {2025},
doi = {10.1002/ddr.70053}
}
EUVIMED